Contact us
Plans and Pricing
Sign Up
Inventicia : Overview | Funder
OverviewContact EnablerDisclaimer
About
Inventicia provides professional consulting, support, and representation services to organizations in the healthcare, life sciences, pharmaceutical, biotechnology, and technology sectors, including strategic and operational consulting, support for digital transformation, regulatory and compliance advice, project management, training and capacity building, concept and strategy development, technology scouting and evaluation, market launch, business development, and the promotion of innovation and partnership projects both domestically and internationally.
The company may establish branches and subsidiaries both domestically and internationally, participate in other companies both domestically and internationally, and conduct all business activities directly or indirectly related to its purpose.
The company may acquire, encumber, sell, and manage real estate both domestically and internationally. It may also provide financing for its own account or for the account of others, and issue guarantees and sureties for subsidiaries and third parties.
Investor Selection Criteria
Investment focus themes and areas
Alternatives to Animal Testing Solutions Computer Modeling, AI, In Vitro solutions, New Approach Methodologies - NAM, Organ-on-a-chip, Organoid, MPS, The three Rs (3R) – Replace, Reduce, Refine
IT & Business Services Design and engineering, Enterprise and data center solutions, Managed services, maintenance and support, Networks and communications, Software development, Tech-Enabled Business Services
Life Science Diagnostics, Drug Development, Small Molecules
HealthCare AI and Digital Health, Biotech, Consumer Healthcare, Digital HealthTech, Healthy Ageing, Life Science, Medical Devices, Medical Devices and Robotics, Medical labs, MedTech, Mental Health
IT / Software / Hardware Artificial Intelligence (AI), Blockchain / WEB3, Creative AI, Cyber and Data Security, DeepTech, Defence Tech, Digital / AI Infrastructure, Digital Platforms, FinTech, GenAI, Green Tech & Environment, Health & Biotech, ICT & Municipality, InsureTech, IoT, Legal & Regulatory, Machine Learning (ML), Marketplace, New Enterprise, Payments, Quantum Computing, Robotics & Automation, SaaS, Social Impact, Space & Beyond, Travel & Transport
HealthTech Accessibility, Biomarkers, Digital Therapeutics, Fitness & Wellness, Healthcare SaaS, Online Pharmacy, Prevention, Remote Monitoring, Sensors, Telemedicine, Wearables, Youth / Elderly focus
Medical Body implants, Connected Health, Diagnostics/Imaging, Genetic engineering, Genome sequencing, Medical devices & instruments, Nano medicines, Neuroscience, Stem cell, Synthetic Biology, Tissue engineering & printing, Vaccination technology
SDG
SDG 3SDG 3
SDG 4SDG 4
SDG 11SDG 11
SDG 12SDG 12
SDG 13SDG 13
SDG 17SDG 17
Gender lens(Female-friendly) Value Chains & Market Systems, Access to Capital (to Female Investees), Female (Co-)Founded, Female(s) in Leadership, Products & Services for Female(s) (as primary beneificiaries), Workplace Equity
Investment type
Equity, Debt, Convertible
Raise amountEUR 100k - 250mn
Ticket size per investmentEUR 5k - 250mn
Investor typeAccrediated Investor, Angel / Individual, Angel / Syndicate Club, Bank, Blended Finance, Corporate, Development Fund, Family Office, Foundation, Fund of Funds, Government, Intermediary, Multi-Family Office, Private Debt, Private Equity, SPV, Venture Capital, Wealth Manager
Investee company's country of incorporation
Afghanistan, Åland Islands, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Sint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territor......See More
Investor's countries Of domicile / nationality
Afghanistan, Åland Islands, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Sint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territor......See More
Investment Selection Criteria
Investment focus themes and areas
Alternatives to Animal Testing Solutions Computer Modeling, AI, In Vitro solutions, New Approach Methodologies - NAM, Organ-on-a-chip, Organoid, MPS, The three Rs (3R) – Replace, Reduce, Refine
IT & Business Services Design and engineering, Enterprise and data center solutions, Managed services, maintenance and support, Networks and communications, Software development, Tech-Enabled Business Services
Life Science Diagnostics, Drug Development, Small Molecules
HealthCare AI and Digital Health, Biotech, Consumer Healthcare, Digital HealthTech, Healthy Ageing, Life Science, Medical Devices, Medical Devices and Robotics, Medical labs, MedTech, Mental Health
IT / Software / Hardware Artificial Intelligence (AI), Blockchain / WEB3, Creative AI, Cyber and Data Security, DeepTech, Defence Tech, Digital / AI Infrastructure, Digital Platforms, FinTech, GenAI, Green Tech & Environment, Health & Biotech, ICT & Municipality, InsureTech, IoT, Legal & Regulatory, Machine Learning (ML), Marketplace, New Enterprise, Payments, Quantum Computing, Robotics & Automation, SaaS, Social Impact, Space & Beyond, Travel & Transport
HealthTech Accessibility, Biomarkers, Digital Therapeutics, Fitness & Wellness, Healthcare SaaS, Online Pharmacy, Prevention, Remote Monitoring, Sensors, Telemedicine, Wearables, Youth / Elderly focus
Medical Body implants, Connected Health, Diagnostics/Imaging, Genetic engineering, Genome sequencing, Medical devices & instruments, Nano medicines, Neuroscience, Stem cell, Synthetic Biology, Tissue engineering & printing, Vaccination technology
SDG
SDG 3SDG 3
SDG 4SDG 4
SDG 11SDG 11
SDG 12SDG 12
SDG 13SDG 13
SDG 17SDG 17
Gender lens(Female-friendly) Value Chains & Market Systems, Access to Capital (to Female Investees), Female (Co-)Founded, Female(s) in Leadership, Products & Services for Female(s) (as primary beneificiaries), Workplace Equity
Investment type
Equity, Debt, Convertible
Investment stageBridge finance, Companies in Transition, Growth Capital, Pre-seed, Project Finance, Seed, Series A, Series B, SME Finance, Venture Debt, Working capital finance
Raise amountEUR 100k - 250mn
Minimum ticket size per investorEUR 5k - 250mn
Investor typeAccrediated Investor, Angel / Individual, Angel / Syndicate Club, Bank, Blended Finance, Corporate, Development Fund, Family Office, Foundation, Fund of Funds, Government, Intermediary, Multi-Family Office, Private Debt, Private Equity, SPV, Venture Capital, Wealth Manager
Investee company's country of incorporation
Afghanistan, Åland Islands, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Sint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territor......See More
Investor's countries Of domicile / nationality
Afghanistan, Åland Islands, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Sint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territor......See More